Just Released - Transplantation Journal - August Issue
New guidelines from ASTS for the application of Normothermic Regional Perfusion are presented in three important papers. These include both general practical and ethical guides as well as specific guidance on both abdominal and thoracic NRP. Elsewhere, the issue addresses waitlist outcomes for liver transplant candidates, details a trial of steroid-free immunosuppression in pediatric liver transplantation, risks of increased bacterial infections following plasma exchange, and effects of concurrent JC viremia with BK nephropathy are explored. The increasingly relevant task of decreasing rejection after xenotransplatation. Our expert reviews this month look into the future of applying machine learning and nanotechnology to clinical transplantation.
Table of Contents
Research Highlights
Game Changer
People in Transplantation
Expert Insight
Original Clinical Science—Liver
- American Society of Transplant Surgeons Normothermic Regional Perfusion Standards: Ethical, Legal, and Operational Conformance
- American Society of Transplant Surgeons Normothermic Regional Perfusion Standards: Abdominal
- Consensus Statement: Technical Standards for Thoracoabdominal Normothermic Regional Perfusion
- Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy
- High Number of Plasma Exchanges Increases the Risk of Bacterial Infection in ABO-incompatible Living Donor Liver Transplantation
- Basiliximab Induction and Postoperative Steroid-free Immunosuppression With Tacrolimus in Pediatric Liver Transplantation: A Randomized Clinical Trial
- Disparities in Liver Transplantation for Nonalcoholic Steatohepatitis in Women
Commentaries
- The Benefit of “Negative Thinking” in Transplant Tolerance Induction
- Furthering Deceased Donor Intervention Research in Canada and the United Kingdom
- Equitable Access to Deceased Donor Livers in the United States: Are We There Yet?
- Reducing Early Graft Loss in Xenotransplantation With Histocompatibility Testing
Reviews
- Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation
- Clinical Deployment of Machine Learning Tools in Transplant Medicine: What Does the Future Hold?
- T-bet+ B Cells in Humans: Protective and Pathologic Functions
- Negative Vaccination Strategies for Promotion of Transplant Tolerance
- Nanotechnology-based Strategies for Molecular Imaging, Diagnosis, and Therapy of Organ Transplantation
Original Clinical Science—General
- Developing Guidance for Donor Intervention Randomized Controlled Trials: Initial Discussions From the Canada-United Kingdom 2022 Workshop
- Cost-effectiveness of Accepting Kidneys From Deceased Donors With Common Cancers—A Modeling Study
- Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study
- Favorable Outcome After Single-kidney Transplantation From Small Donors in Children: A Match-controlled CERTAIN Registry Study
- Concurrent JCPyV-DNAemia Is Correlated With Poor Graft Outcome in Kidney Transplant Recipients With Polyomavirus-associated Nephropathy
- Nonadherence to Immunosuppressant Therapy of Kidney Transplant Candidate Patients: External Validation of the KATITA-25 Scale
Letters to the Editor
- Long-term Outcomes From the UK Pilot of Early Liver Transplantation for Severe Alcohol-related Hepatitis
- The Impact of Being Born and Growing Up Postliver Transplantation, Looking Back 35 y Later
- Precision Delivery of Therapeutics to the Intestine: A Case Series of Superselective Steroid Administration in Pediatric Intestinal Transplant Recipients
- Protocol Biopsies in Patients With Subclinical De Novo DSA After Kidney Transplantation: Long-term Graft Survival
July 30 Special Webinar - On the Occasion of World Day Against Trafficking in Persons
In recognition of the United Nations World Day Against Trafficking in Persons, The Transplantation Society (TTS) is hosting a special webinar organized by the DICG on July 30th. This event will highlight the critical issue of trafficking in persons and its impact on transplantation practices worldwide. Join us to learn from experts, share insights, and discuss solutions to combat this global challenge. Don't miss this important opportunity to engage and make a difference.
Upcoming Webinar Presentations
Transplantation Journal Highlights
Transplantation - Social Media Content
The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era
Alcohol liver disease (ALD) may coexist with hepatitis C (HCV) in many transplant recipients (alcoholic cirrhosis with hepatitis C [AHC]). Our objective was to determine whether there were differences in postliver transplantation outcomes of patients with AHC when compared with those with alcoholic cirrhosis (AC) and/or alcoholic hepatitis (AH).
Breaking News: Digital Editor Team – Transplantation Journals
We are excited to announce the new Digital Editors Team of Transplantation and Transplantation Direct. This team will be in charge of the journals’ social media content, dissemination, and engagement extending the traditional role of the journal’s editors through dynamic social media platforms. As primary responsibilities, digital editors will facilitate strategies for digital interaction and dialogue around publications.
Transplantation Direct - Social Media Content
The Impact of Donor Body Mass Index on Safety and Outcomes in Living Donor Liver Transplantation: An Analysis of the National United States Database
The prevalence of obesity is rising in the general population. Donor obesity (body mass index ≥30 kg/m2) may potentially reduce the donor pool and impact outcomes in living donor liver transplantation (LDLT).
Mycophenolate Dose Reduction in Tacrolimus-based Regimens and Long-term Kidney Transplant Outcomes in Australia and New Zealand
Mycophenolate dose reduction (MDR) is associated with acute rejection and transplant failure in kidney transplant recipients (KTRs). The optimal dose to prevent rejection and reduce complications remains poorly defined in tacrolimus-based regimens.
ISODP Journal Watch Newsletter - July 2024
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada